Beta
359812

Evaluation of different biochemical markers and imaging modalities in type 2 diabetes mellitus patients with and without albuminuria

Article

Last updated: 21 Dec 2024

Subjects

-

Tags

-

Abstract

Objective
The aim of this study was to evaluate the effects of albuminuria on different biochemical markers, different target organs, and subclinical atherosclerosis in patients with type 2 diabetes mellitus (T2DM).
Patients and methods
Sixty T2DM patients were divided into three equal groups according to their levels of albuminuria − namely, normoalbuminuria, microalbuminuria, and macroalbuminuria. Renal function tests, glycemic status markers, serum electrolytes, high-sensitivity C-reactive protein, fibroblast growth factor 23, vitamin D, intact parathyroid hormone, and fractional excretion of phosphate (FePO) were measured. Patients also underwent renal arterial duplex, Doppler echocardiography, and estimation of the carotid intima–media thickness.
Results
Blood urea nitrogen and creatinine clearance were significantly higher in patients with albuminuria. Fasting blood glucose, postprandial blood glucose, and glycosylated hemoglobin levels were significantly higher in patients with albuminuria. There were no statistically significant differences among the studied groups as regards serum electrolytes. Fibroblast growth factor 23 levels were significantly higher in patients with albuminuria. In patients with macroalbuminuria, vitamin D levels were significantly lower, whereas intact parathyroid hormone and high-sensitivity C-reactive protein levels were significantly higher. There were no statistically significant differences among the studied groups as regards FePO. There were no statistically significant differences between the studied groups as regards renal resistive indices, presence or absence of left ventricular hypertrophy, or carotid intima–media thickness. Left ventricular ejection fraction was significantly lower in patients with albuminuria.
Conclusion
In T2DM patients with albuminuria (especially macroalbuminuria), several markers of renal complications are elevated, denoting a high-risk population for the development of end-stage renal disease. Moreover, markers of asymptomatic left ventricular systolic dysfunction were observed, denoting a higher risk for cardiovascular morbidity and mortality.

DOI

10.4103/2356-8062.197572

Keywords

albuminuria, diabetic nephropathy, Fibroblast Growth Factor 23

Authors

First Name

Amr Mohamed

Last Name

Ebeid

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Doaa Ibrahim

Last Name

Hashad

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mohamed Ahmed

Last Name

Sadaka

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mohamed Mahmoud

Last Name

Elshafie

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mohamed Mohamed

Last Name

Sakr

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Samah Ibrahim

Last Name

Idris

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

2

Article Issue

2

Related Issue

48414

Issue Date

2016-05-01

Receive Date

2016-05-04

Publish Date

2016-05-01

Print ISSN

2356-8062

Online ISSN

2356-9409

Link

https://ejode.journals.ekb.eg/article_359812.html

Detail API

https://ejode.journals.ekb.eg/service?article_code=359812

Order

359,812

Publication Type

Journal

Publication Title

​​Egyptian Journal of Obesity, Diabetes and Endocrinology

Publication Link

https://ejode.journals.ekb.eg/

MainTitle

Evaluation of different biochemical markers and imaging modalities in type 2 diabetes mellitus patients with and without albuminuria

Details

Type

Article

Created At

21 Dec 2024